SILVERARC CAPITAL MANAGEMENT, LLC – Aclaris Therapeutics, Inc. Transaction History
SILVERARC CAPITAL MANAGEMENT, LLC portfolio value:
$8.55M
portfolio value
SILVERARC CAPITAL MANAGEMENT, LLC quarter portfolio value change:
+12.75%
quarter
Aclaris Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +0.78% | 4.23K shares | 1.02M | $15.74 | 543.77K |
| Q2 2022 | share | Increase | +95.96% | 264.21K shares | 2.78M | $13.96 | 539.54K |
| Q1 2022 | share | Decrease | -3.81% | -10.89K shares | 585K | $17.24 | 275.33K |
| Q4 2021 | share | Increase | +65.14% | 112.89K shares | 1.04M | $14.33 | 286.22K |
| Q3 2021 | share | Decrease | -8.16% | -15.39K shares | -194K | $18 | 173.32K |
| Q2 2021 | share | Decrease | -43.96% | -148.01K shares | -5.17M | $17.56 | 188.71K |
| Q1 2021 | share | Increase | 0.00% | 336.73K shares | 8.48M | $25.2 | 336.73K |